Erythema nodosum-like panniculitis associated with immune checkpoint inhibitor therapy: Two cases reporting a rare cutaneous adverse event

Jolanta Pach; Katherine Moody; Nan Ring; Gauri Panse; Michael Zhang; Sandhya Deverapalli; Jonathan Leventhal

doi:10.1016/j.jdcr.2021.05.002

Erythema nodosum-like panniculitis associated with immune checkpoint inhibitor therapy: Two cases reporting a rare cutaneous adverse event

JAAD Case Rep. 2021 May 27:13:118-120. doi: 10.1016/j.jdcr.2021.05.002. eCollection 2021 Jul.

Authors

Jolanta Pach¹, Katherine Moody², Nan Ring¹, Gauri Panse¹, Michael Zhang³, Sandhya Deverapalli², Jonathan Leventhal¹

Affiliations

¹ Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
² Department of Dermatology, Tufts University School of Medicine, Boston, Massachusetts.
³ Inform Diagnostics, Needham, Massachusetts.

No abstract available

Keywords: EN, erythema nodosum; ICPi, immune checkpoint inhibitor; erythema nodosum; immune checkpoint inhibitors; immune-related adverse event; panniculitis.

Publication types

Case Reports

Grants and funding

UL1 TR001863/TR/NCATS NIH HHS/United States